Microproteins in cancer: identification, biological functions, and clinical implications
Trends in Genetics · 2025-02 · 41 (2) · 146-161
DOI: 10.1016/j.tig.2024.09.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Genetics, 2025-02. Verfasst von Damon A Hofman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands; Oncode Institute, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Ben and Catherine Ivy Foundation, National Institutes of Health.
Abstract (Originalsprache)
Cancer continues to be a major global health challenge, accounting for 10 million deaths annually worldwide. Since the inception of genome-wide cancer sequencing studies 20 years ago, a core set of ~700 oncogenes and tumor suppressor genes has become the basis for cancer research. However, this research has been based largely on an understanding that the human genome encodes ~19 500 protein-coding genes. Complementing this genomic landscape, recent advances have described numerous microproteins which are now poised to redefine our understanding of oncogenic processes and open new avenues for therapeutic intervention. This review explores the emerging evidence for microprotein involvement in cancer mechanisms and discusses potential therapeutic applications, with an emphasis on highlighting recent advances in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands; Oncode Institute, Utrecht, The Netherlands.
- Department of Pediatrics, Division of Pediatric Hematology/Oncology and Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: prensner@umich.edu.
- Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands; Oncode Institute, Utrecht, The Netherlands. Electronic address: s.a.a.vanheesch@prinsesmaximacentrum.nl.
Förderung
- NCI NIH HHS
- Ben and Catherine Ivy Foundation
- National Institutes of Health
- Stichting Villa Joep
- Andrew McDonough B+ Foundation
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Alex's Lemonade Stand Foundation for Childhood Cancer
- National Cancer Institute
Zitieren
APA
Hofman, D. A., Prensner, J. R., & van Heesch, S. (2025). Microproteins in cancer: identification, biological functions, and clinical implications. Trends in Genetics, 41(2), 146-161. https://doi.org/10.1016/j.tig.2024.09.002
Vancouver
Hofman DA, Prensner JR, van Heesch S. Microproteins in cancer: identification, biological functions, and clinical implications. Trends in Genetics. 2025;41(2):146-161. doi:10.1016/j.tig.2024.09.002
BibTeX
@article{Hofman2025,
author = {Hofman, Damon A and Prensner, John R and van Heesch, Sebastiaan},
title = {Microproteins in cancer: identification, biological functions, and clinical implications},
journal = {Trends in Genetics},
year = {2025},
volume = {41},
number = {2},
pages = {146--161},
doi = {10.1016/j.tig.2024.09.002}
}
EUVIMED